In platelets, splicing and translation occur in the absence of a nucleus. However, the integrity and stability of mRNAs derived from megakaryocyte progenitor cells remain poorly quantified on a transcriptome-wide level. As circular RNAs (circRNAs) are resistant to degradation by exonucleases, their abundance relative to linear RNAs can be used as a surrogate marker for mRNA stability in the absence of transcription. Here we show that circRNAs are enriched in human platelets 17-188 fold relative to nucleated tissues, and 14-26 fold relative to samples digested with RNAseR to selectively remove linear RNA. We compare RNAseq read depths inside and outside circRNAs to provide in silico evidence of transcript circularity, show that exons within circRNAs are enriched on average 12.7X in platelets relative to nucleated tissues, and identify 3162 genes significantly enriched for circRNAs, including some where all RNAseq reads appear to be derived from circular molecules. We also confirm that this is a feature of other anucleate cells through transcriptome sequencing of mature erythrocytes, demonstrate that circRNAs are not enriched in cultured megakaryocytes, and that linear RNAs decay more rapidly than circRNAs in platelet preparations. Collectively, these results suggest that circulating platelets have lost over 90% of their progenitor mRNAs, and that translation in platelets occurrs against the backdrop of a highly degraded transcriptome. Finally, we find that transcripts previously classified as products of reverse transcriptase template switching are both enriched in platelets and resistant to decay, countering the recent suggestion that up to 50% of rearranged RNAs are artefacts.
INTRODUCTION
Platelets are small, anucleate, circulating blood cells derived from large polyploid megakaryocyte progenitors [1] . They are vital for basic functions such as hemostasis, wound healing and angiogenesis [2] . Unlike anucleate erythrocytes which have a lifespan of ~4 months and have greatly reduced ribosome numbers [3] , platelets are short lived (~8-11 days [4] ), translationally competent [5] , and some genes have been shown to undergo cytoplasmic splicing upon platelet activation [6, 7] . Consistent with these observations, recent RNAseq analyses have defined a complex transcriptome [8] [9] [10] [11] . However, some transcripts believed to contribute to platelet function are expressed at very low levels in RNAseq data [11] , and attempts to integrate transcriptome and proteome data have given conflicting results [12] [13] [14] [15] . In the absence of nuclear transcription, RNAs within platelets are assumed to degrade over time. Although the abundance of individual mRNAs have been shown to fall in platelets stored at ambient temperatures [16] , the stability and integrity of mRNAs within circulating platelets is poorly characterised at the transcriptome level. However, this is highly relevant to functional inferences drawn from RNAseq data [9, 11, 15, 17, 18] .
Transcripts with rearranged exon order are now known to be very common in eukaryotic organisms, and are characterised at the sequence level by "back-splice" exon junctions inconsistent with the underlying genomic DNA [19] [20] [21] [22] [23] [24] . Evidence for linear and polyadenylated structures has been presented [20, 25, 26] , but it is now clear that most are both circular (circRNAs) and cytoplasmic [21] [22] [23] . Recent experiments using minigene expression constructs have established that intronic repeats flanking rearranged exons can promote circularisation, and that circRNAs primarily utilise canonical splice sites [27] [28] [29] [30] and can be regulated by RNA binding proteins [29, 31] . Although two non-coding cytoplasmic circRNAs have been shown to act as miRNA sponges [22, 26] , and circRNAs with retained introns (Exon-Intron or EIcircRNAs) can enhance transcription of their parental genes through interaction with U1 snRNP and RNA PolII [32] , the vast majority of circRNAs consist of exons from protein encoding genes and have no known function [22, 33] . Circular RNAs are resistant to attack by exonucleases involved in the regulation of mRNA [34] and resistance to one, RNAseR, has been used to define them [23, 35] . Furthermore, blocking of transcription leads to an increase in circRNA levels relative to linear [23] . This differential stability raises the possibility that the abundance of circRNAs relative to linear forms could provide insight into the platelet transcriptome. Here, we analyse the circRNA population of platelets, and compare it to populations in nucleated cells, enucleated erythrocytes, and cells where linear RNA has been digested with RNAseR. We show that circRNAs are highly enriched in both platelets and erythrocytes relative to nucleated tissues, and confirm this experimentally using qPCR. We then analyse platelet circRNAs are significantly enriched relative to nucleated cell types, including some genes where only circRNAs producing exons are represented within the RNAseq data. We also use qPCR to establish that circRNAs are not enriched in cultured magakaryocytes and that, over time, the levels of linear RNAs fall relative to circRNAs in platelet preparations. Our results suggest that over 90% of mRNAs have been lost from circulating platelets, and have potentially important implications for both platelet biology and our understanding of circRNAs.
MATERIAL AND METHODS

Datasets used
In silico analyses (RNAseq, circRNA abundance and decay analysis) were performed on RNAseq data generated during the study and on 36 publicly available datasets. 24 of these were ribosomal RNA depleted total RNA fractions sequenced on the Illumina platform [11, 23, 27, 36, 37] , 2 polyA+ selected samples sequenced on the Ilumina platform [11, 38] , and 10 non-ribosomal RNA depleted total RNA sequenced on the SOLiD platform [15] . For details, see Supplementary Methods and Supplementary Table S1 .
Erythrocyte RNAseq
Ribosome depleted RNAseq of total RNA from Red Blood cells was performed by AROS Applied Biotechnology (Aarhus, Denmark) using the TruSeq RiboZero Stranded mRNA LT kit (Illumina). The library was sequenced using a paired-end 100 base pair protocol on a Hi Seq 2000 (Illumina), all according to manufacturer's recommendations (see Supplementary Methods).
circRNA identification
Identification of back-splice exon junctions was performed using PTESFinder Pipeline v. 1 (http://sourceforge.net/projects/ptesfinder-v1/). This identifies all RNAseq reads which map in inverted order but the same orientation to the same RefSeq entry, generates models of these junctions, and re-maps all reads under analysis to the models. It then eliminates potential false positives through removal of reads which do not utilise known exon junctions, and reads which map equally well or better to the genomic or transcriptome reference (see Supplementary Methods and   Supplementary Table S2 for details).
Biological samples: origin and preparation
RNAs from human solid tissues were obtained from Biochain (Amsbio, UK). Red Blood Cells were obtained from the Scottish National Blood Transfusion Service (SNBTS) in accordance with the terms of the standard donor consent form and information, and with approval of the SNBTS Sample Governance Committee. Cord blood was obtained after informed consent under a protocol approved by the National Research Ethics Service (Cambridgeshire 4 Research Ethics Committee ref.
No. 07/MRES/44). Whole blood samples were collected from healthy volunteers with approval from Newcastle University's Faculty of Medical Sciences Ethics Committee. Platelets and platelet rich plasma (PRP) were isolated according to a protocol which utilises a platelet inhibitory cocktail [39] .
Isolation of peripheral blood mononuclear cells (PBMCs) and red blood cells (RBCs) was performed using Histopaque-1.077 density gradient (Sigma-Aldrich) according to manufacturer's instructions.
Megakaryoctes were cultured and isolated according to the protocol of Tijssen et al. [40] . For further details see Supplementary Methods.
RNA isolation and cDNA generation
RNA was isolated using Trizol (Lifetechnologies) and treated with DNase I (Promega) according to manufacturer's instructions. RNA quantitation was performed using the NanoDrop ND-1000 spectrophotometer (Thermo Scientific) and quality was assessed using the Agilent 2100
Bioanalyser (Agilent Technologies). cDNA was synthesised using high capacity cDNA kits (Applied Biosystem), random hexamers, and Moloney murine leukaemia virus (MMLV) unless stated otherwise.
Real time PCR
Real time PCR was performed using Taqman mastermix (Lifetechnologies) as described previously [20] . Where linear and circular structures from the same gene were analysed, a common probe was used. Primers and assay efficiencies are given in Supplementary Table S1. Transcript expression was normalised using the ∆CT method relative to the geometric mean of 4 housekeeping genes (GAPDH, PPIA, TUBB, GUSB) analysed using TaqMan gene expression assays (Applied Biosystems). Circular transcripts were also normalised against the linear transcript from the same gene where appropriate. Reactions were performed in 10 µl volumes in 384 plates using 
RESULTS
Platelets are highly enriched for circRNAs
We first identified 3 publicly available RNAseq datasets from human platelets [9, 11, 15] , one of which had a sequence read length long enough for the identification of back-splice junctions within circRNAs, and included samples processed to retain unpolyadenylated RNAs (Array express i.d.
E-MTAB-1846; 100bp Illumina ribosome depleted total RNAseq from 3 individuals, and polyA+
RNAseq from 1 individual [11] ). Analysis of the 3 total RNAseq samples using a back-splice junction discovery pipeline (PTESFinder see Methods) identified 33829 distinct structures consistent with circRNAs (Supplementary Figure 1 and Supplementary Table S3 ), approximately 4-5X more than reported for Fibroblasts [23] and ~15X more than reported for leukocytes and HEK293 cells [22] in libraries of comparable size. Furthermore, it identified 62%-64% of structures previously identified within RNAseq data from cell lines digested with RNAseR to selectively remove linear transcripts [23, 27] , consistent with them being primarily derived from circRNAs. Despite the large number identified, the majority are not platelet specific, as 24632 (~73%) were also present in one or more of 15 Figure S1 ).
ENCODE RNAseq datasets previously mined by Salzman et al. (2013) (Supplementary
Having identified an apparent abundance of circRNAs in platelets, we then used PTESFinder to identify circRNAs within other publicly available datasets generated using ribosome depleted total RNAseq and sequenced using the Illumina platform. These consisted of a panel of 12 human tissues [37] , ENCODE cell lines [41] , and cell lines treated with RNAseR to selectively remove linear RNAs [23, 27] . To enable comparison with a distinct anucleate cell type, we also generated >120 million 100bp paired-end Illumina RNAseq reads from total RNA extracted from leukocyte depleted red blood cells We also analysed the platelet polyA+ sample from E-MTAB-1846 and identified 841 circRNA structures from 453 genes. However, their nucleotide composition was found to be significantly enriched for A residues relative to structures present only in platelet total RNA (Chi squared = 12317 p<2.2e-16, Supplementary Table S4 ). As this suggests that these structures are non-polyadenylated circRNA transcripts rich in A nucleotides, they were not analysed further.
More than 600 platelet genes generate over 20 distinct circRNAs.
To illustrate the variation in circRNA distributions, the numbers of circRNA structures identified per gene are displayed for 4 samples in Figure 2A . Strikingly, both platelets and the fibroblasts digested with RNAseR (which increases circRNA levels by degrading liner RNAs) have large numbers of genes generating >15 distinct circRNA structures. For example, the platelet sample has >600 genes each with >20 different circRNAs. Furthermore, as shown in Table 1 , individual structures in anucleate samples are supported by much larger back-splice junction read counts than in nucleated tissues (p=2.7x10 -4 anucleate v nucleated counts, Wicoxon rank sum test). All 3 platelet samples have over 1000 structures supported by over 100 reads, in sharp contrast to undigested nucleated samples. As an example of the diversity of structures and read support within platelets, the 49 inferred circRNA structures identified within the XPO1 gene are shown in Figure 2B , with supporting read counts ranging from 1 (E8-E5 and E16-E7) to 4045 (E4-E2). It is noteworthy that all 21 of the internal exons of this gene are encompassed by one or more circRNA (illustrating that most exons within some genes can contribute to circRNAs), and that only 11 of these structures were identified previously in RNAseR digested H9 RNA [27] .
Real Time PCR confirmation of high circRNA transcript levels in anucleate cells.
To experimentally confirm the enrichment of circRNAs in both anucleate cell types, we used qPCR to assess the relative levels of linear and circRNAs. We first assayed expression of the mononucleocyte expressed CD45 antigen (PTPRC), and performed cell counts to confirm that nucleated white blood cells were being efficiently removed during platelet isolation (Supplementary Figure S2 and Supplementary Methods). As a precaution against Reverse Transcriptase (RT) specific artefacts which have been reported [42] we also checked that all circRNAs being analysed could be amplified using templates generated with both AMV and MMLV RTs (Supplementary Figure S3) . We then analysed the abundance of two known circRNA structures from MAN1A2 (E4-E2 and E5-E2 [22] ) relative to the canonical MAN1A2 transcript, two structured from PHC3 (a gene expressed in platelets for which assays were already available [20] ), and an additional 7 abundant circRNAs together with their associated linear RNAs (see Supplementary Table S1 ). For each, paired assays with a common probe were used ( Figure 3A ).
Both of the MAN1A2 circRNA junctions are much more abundant in platelets and RBCs than the linear mRNA ( Figure 3B ). However, they are less abundant than the linear transcripts in virtually all other nucleated tissues analysed. This is consistent with both the RNAseq data and previous analyses of nucleated tissues [20, 22] . The other 9 circRNAs are also all expressed at higher levels in platelets and RBCs than their corresponding linear structures ( Figure 3C ), with circRNAs from SMARCA5, UBXN7 and PNN registering ~6-10 cycles before their corresponding linear RNAs, suggesting that they are ~50-1000 fold more abundant. In contrast, all are expressed in nucleated cells at an equivalent or lower level than their linear counterparts. Collectively, the difference in relative expression levels of linear and circRNAs between anucleate and nucleated tissues is highly significant (p=2.7x10 -12 Wilcoxon rank sum test).
Finally, the impact of RNAseR digestion upon expression was also assessed ( Figure 3D ).
Digestion increases the expression of all back splice junctions relative to the canonical linear junctions in each cell type analysed (p=7.8x10 -3 Wilcoxon paired rank sum test, mock digest v RNAseR digest), although the MAN1A2 E5-E2 back-splice shows only a marginal increase in the platelet sample ( Figure 3D ). This confirms that these structures include circRNAs. However, the impact of RNAseR digestion upon the relative levels of linear and circRNAs is more pronounced in peripheral blood mononuclear cells (PBMC) and in HEK293 cells than in either anucleate sample (p<0.02, Wilcoxon paired rank sum test for all pairwise nucleated v anucleated comparisons).
For some genes, only reads from circRNA producing exons are detected in platelets
The abundance of individual circRNAs relative to mRNAs from the same loci has previously been estimated in silico by comparing back-splice junction read counts to flanking canonical junction counts [20, 21, 43] . However, because most circRNA producing genes generate multiple overlapping structures (e.g. Figure 2B and Supplementary Table S3 ), the canonical junctions flanking one circRNA are often present within others. We therefore performed a transcriptome-wide analysis where we compared the average read count within exons which contribute to circRNAs, to the read count in exons which do not (see Supplementary Table S5 ). For each gene we calculated the RPKM across all exons internal to all known circRNA structures (RPKMI), and the RPKM across exons external to all known circRNAs (RPKME). The former is a measure of both linear and circRNA expression, the latter linear only. Box and whisker plots showing RPKMI/RPKME ratios for all circRNA producing genes in all samples are presented in Figure 4A . The ratios from individual genes extend over 6-8 orders of magnitude for each sample, but what is most striking is that the median RPKMI/RPKME ratios of the anucleate samples are approximately 12 times higher than nucleated tissues, and approximately 5 times higher than samples digested with RNAseR ( Figure 4A ). The distribution of RNAseq reads within these genes therefore reflects the pattern of circRNA structures inferred from exon-junction read counts alone (Figures 1 and 2) , and provides further evidence that the back-splice junctions are predominantly derived from circRNAs.
To identify genes significantly enriched for circRNAs in platelets, for each gene we then estimated the contribution of circRNA producing exons to total transcription by calculating RPKMI/(RPKMI + RPKME) ratios, and compared ratios in the platelet samples to ratios in the 12 nucleated tissues using the Wilcoxon rank test (p-value = 0.05, Benjamin and Hochberg false discovery rate = 0.01). Out of 8041 circRNA producing genes analysed, 3162 showed significantly enriched transcription from circRNA producing exons in platelets (Supplementary Table S5 ). When the ratios from all genes with an average RPKM >1 in platelets are plotted ( Figure 4B ), it can be seen that for the vast majority of enriched genes the contribution of circRNA exons to total transcription is >0.6 in nucleated tissues, but >0.8 in platelets. Furthermore, transcription from circRNA producing exons for 457 genes exceeds an average of 99% in the platelet samples, and for 15 genes it is 100% in all 3 samples (Supplementary Table S5 ) indicating that all reads detected are from circRNA producing exons. As this assay is not dependent on exon junction counts, which require long sequence reads for accurate detection, we were also able to apply it to one of the SOLiD platelet RNAseq datasets [15] , and confirmed the presence of similar patterns of circRNA exon enrichment (e.g. Supplementary Figure 4 , and Supplementary Data File 1).
Reads from circRNA producing exons are enriched in platelets by up to 3000 fold
To estimate the magnitude of circRNA exon enrichment for each gene in platelets relative to other tissues, we further analysed genes with an average RPKMI >1 by normalising their mean platelet RPKMI/RPKME ratio against the mean RPKMI/RPKME ratio from all 12 nucleated samples. The average enrichment was 12.7X for all genes, and 22X for the 3162 significantly enriched genes, with the highest enrichment being 3590X for TMEM181 ( Figure 4C and Supplementary Table S5 ). To illustrate these extreme levels of enrichment, RNAseq read counts and circRNA junction read counts for 4 enriched genes from a single platelet sample are shown in Figure 5 . The vast majority of platelet RNAseq reads from PNN (enrichment 2189X) map to exons 7 and 8 which correspond to the most abundant circRNA ( Figure 5A ); the majority of reads from SLC20A2 (enrichment 152X) map to the abundant circRNAs involving exons 3-5 ( Figure 5B ); all reads from POMT1 (enrichment 127X) map to exons within its only circRNA (E4-E3 Figure 5C ), while for PHC3 (enrichment 240X), the reads map largely to the abundant E6-E5 and E7-E5 structures ( Figure 5D ).
Although all of our in silico analyses point to enrichment specifically in anucleate cells, no total RNAseq data has been generated from megakaryocytes, the direct progenitors of these cells.
For all genes with assays available, we therefore also analysed the relative levels of linear and circRNAs in megakaryocytes cultured from cord blood. These were harvested after 10 days, when >70% of cells were positive for CD41 and CD42 (See Supplementary Methods). The results, presented in Figure 5 panels E and F, establish that megakaryocytes have very similar relative levels of linear and circRNA compared to other nucleated cell types ( Fig 2B) ; all circRNAs are expressed at a much lower relative to linear RNAs than in platelets (p=1.4x10 -6 Wilcoxon paired rank sum test across all structures). This is consistent with circRNA enrichment occurring after platelet formation.
Confirmation of differential decay of linear and circRNAs in platelet preparations
Human mRNAs are subject to a wide variety of decay pathways [44] , and exhibit extensive variation in decay rates [45] [46] [47] . To investigate decay in platelets, we first correlated the change in transcript abundance between megakaryocyte PolyA+ RNA and platelet PolyA+ RNA with published estimates of mRNA half-life [45] . This identified a weak but highly significant correlation, despite the difference in cell types between datasets analysed, with short half-life genes showing a more pronounced reduction in transcript abundance (r=0.17, p=3.35e-44, Figure 6A ). This is consistent with a transcriptome-wide role for mRNA decay in platelet expression levels.
To experimentally investigate differential decay, we then used Real Time PCR to analyse changes in linear and circRNA abundance in platelet rich plasma (PRP) over time (see Methods).
Consistent with previous analysis [16] initial experiments suggested that all transcript levels remained stable at 4 o C, but that degradation of mRNA could be detected when incubation temperature was elevated to 37 o C (data not shown). We therefore assayed the relative abundance of linear and circRNAs in PRP from 3 individuals, before and after incubation at 
DISCUSSION
Platelets are anucleate yet retain the machinery required for splicing and translation, and there is extensive evidence that specific genes are translated in activated platelets [5] [6] [7] [48] [49] [50] . As a result, recent platelet transcriptome analyses have generated considerable interest [8, 17, 18] . However, here we have shown that the platelet transcriptome is significantly enriched for circRNAs as assayed using back-splice junction counts, real-time PCR, and an RNAseq comparative read depth approach.
Back-spice reads are enriched 17-188 fold relative to nucleated tissues, and over 3000 genes have a statistically significant enrichment of reads from circRNA producing exons. Furthermore, for some genes only RNAseq reads derived from circRNA producing exons are detected within platelet samples, highlighting the impact this enrichment will have upon RNAseq based estimates of expression levels. We have also established that circRNAs are not enriched in cultured megakaryocytes compared to other nucleated cell types.
While we cannot formally rule out the possibility that some circRNA enrichment occurs at the transcriptional level late in megakaryocyte maturation, collectively our results suggest that enrichment occurs specifically in platelets, after the loss of nuclear influence. The similarly high levels of enrichment observed in anucleate RBCs are consistent with this, while the observed reduction of linear RNAs relative to circRNAs in platelets incubated at 37 o C confirms that differential decay occurs. The overall level of enrichment of RNAseq reads from circRNA producing exons is consistent with platelet mRNA levels being at least 90% lower than within nucleated tissues (average enrichment 12.7X for genes with RPKMI>1). Although this is a rough and indirect estimate, it is likely to be conservative as it assumes no degradation of circRNAs. Furthermore, the fraction of translatable RNAs is likely to be even lower, as our analysis has only considered RNA abundance, not structural integrity. This is consistent with the suggestion that platelet lifespan may be determined by translational competence [51] .
Degradation has been assumed to be a feature of the platelet transcriptome based purely on their anucleate nature [51] . Mitochondrially encoded genes are among the most highly expressed [52] , levels of individual mRNAs have been shown to fall when platelet preparations are incubated at ambient temperature [16] , and there is some evidence that translation is reduced in aged platelets relative to the whole population [51] . Consideration of mRNA half lives alone would suggest that mRNA degradation is likely to be substantial, unless platelet specific mechanisms exist to counteract it. If we assume the average age of circulating platelets is 4 days (and that functional separation from the nucleus occurs at day 0), then mRNA half-lives [45] would predict gene specific reductions in expression ranging from 1.2X to 720X, with a mean reduction of 14X. Our estimate of 12.7X based on RNAseq read counts is broadly consistent with this, despite the fact that RPKMI/(RPKMI + RPKME) ratios will vary between genes due to a variety of factors which are unrelated to circularity, including differential isoform abundance, overlapping UTRs between neighbouring genes, and the reduction in RNAseq read coverage close to transcript termini.
Extensive mRNA degradation provides a simple explanation for conflicting reports concerning the correlation between the platelet transcriptome and proteome [12, 13, 15, 53] , and for the presence of proteins in platelets without corresponding mRNAs [15, 50] . It can also explain why many genes which have been shown to be spliced and/or translated in platelets, such as Tissue Factor (F3) [7, 54] , IL1B [55] , SLC23A2 [56] , FGA, FGB, FGG, ALB [57] , and BCL3 [58] , are present at very low levels or not at all in some RNAseq datasets [10, 11] . Collectively, our results indicate that translation in platelets occurs against the backdrop of a rapidly degrading transcriptome, that platelets will differ in their translational potential in an age dependent manner, and that RNAseq analyses targeted towards intact species which are capped [15, 18] or polysome bound will be required to analyse translational potential in these cells effectively.
CircRNAs have been identified from RNAseq data by the back-splice exon junctions they contain, and such junctions have been taken prima facie as evidence of circularity [24, 33, 59 , 60]. Our exonpartitioned analysis of read-depth provides additional in silico evidence that the structures which contain these junctions are primarily circular, as trans-splicing of independent linear pre-mRNA [20, 42] would affect exons both up and downstream of the back-spliced exons. The higher number of circRNAs identified in platelets compared to RNAseR digested total RNA is, however, surprising as RNAseR selectively digests linear transcripts. This suggests that RNAseR removal of linear RNAs in vitro may be a relatively crude tool when compared to decay in vivo. This could be due both to limitations of enzyme specificity, and the lability of RNA post extraction. The significant enrichment of A nucleotides within back-splice transcripts present within platelet polyA+ RNA is also noteworthy as it means their presence within oligodT selected RNA fractions does not necessarily imply polyadenylation, as has been suggested previously [20, 42] . This may adversely affect the accuracy of RNAseq based mRNA expression estimates of the genes involved.
It has recently been suggested that up to 50% of RNAs with back splice exon junction are reverse transcriptase artefacts. This was extrapolated from an analysis of 13 back-splice RNAs where the only 6 RNAs which could be independently validated were those which could be amplified using both AMV and MMLV reverse transcriptases [42] . However, among the 7 RNAs which could not be validated, 4 were intragenic back-splice structures and all are present within platelets: The backsplice counts of 3 (PHC3 E6-E5, CNTLN E5-E3, RERE E3-E3) are enriched relative to other tissues (~1000X, ~100X, ~4X), and read counts in exons between each back-splice are also enriched (240X, ~30X, 500X) indicative of circRNAs. Furthermore, the PHC3 E6-E5 structure degrades more slowly than linear RNA, is resistant to RNAseR digestion [23] , and in our hands can be amplified from cDNA generated using either MMLV or AMV (Supplementary Figure S3) . These diverse lines of evidence suggest that there may not be a straightforward relationship between RT-specificity and artefacts as previously suggested [42] .
Finally, cellular levels of circRNAs are known to be low in proliferating and neoplastic human cells [43, 60] but to increase during differentiation of ES cells [61] and during Drosophila development [62] , suggesting that they may be a biomarker for ageing. Among nucleated tissues they are highest in both human and Drosophila neural tissues [43, 62] and are particularly enriched in synapses [43] . They are also enriched in exosomes [63] . These observations, together with the presence of miRNA binding sites within circRNAs [62] , and the dynamic expression patterns of some [43] , implies that they may be of functional importance. CircRNA levels can be modulated by intronic homology [23, 27, 28] , and splicing factors such as Quaking [31] and Muscleblind [29] . However, our qPCR analysis of transcripts in MKs suggests that the extreme enrichment in platelets reported here is not due to modulation at the pre-mRNA level within progenitor cells. With no transcription in platelets it can, therefore, only be accounted for by differential degradation/decay. The differential degradation and very high levels of enrichment reported here suggests that, even if the relative levels of linear and circRNAs from each gene remain constant at the level of transcription, subtle changes in expression level, rates of mRNA export, changes in the cell cycle [60], changes in nuclear and cytoplasmic volumes, and distance from the nucleus could all alter relative abundance over time.
Many reported differences in linear and circRNA levels could, therefore, be due to their stability alone. 
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